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Summary
It is currently unclear whether tissue changes surrounding multifocal epithelial tumors are a cause
or consequence of cancer. Here, we provide evidence that loss of mesenchymal Notch/CSL
signaling causes tissue alterations, including stromal atrophy and inflammation, which precede
and are potent triggers for epithelial tumors. Mice carrying a mesenchymal-specific deletion of
CSL/RBP-Jκ, a key Notch effector, exhibit spontaneous multifocal keratinocyte tumors that
develop after dermal atrophy and inflammation. CSL-deficient dermal fibroblasts promote
increased tumor cell proliferation through up-regulation of c-Jun and c-Fos expression and
consequently higher levels of diffusible growth factors, inflammatory cytokines, and matrix
remodeling enzymes. In human skin samples, stromal fields adjacent to cutaneous squamous cell
carcinomas and multifocal premalignant actinic keratosis lesions exhibit decreased Notch/CSL
signaling and associated molecular changes. Importantly, these changes in gene expression are
also induced by UVA, a known environmental cause of cutaneous field cancerization and skin
cancer.
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Introduction
Squamous cell carcinomas are very common malignant tumors in humans, occurring in
organs such as skin, oral mucosa and upper digestive tract, lung, and urogenital apparatus.
Analysis of these tumors led, more than 60 years ago, to the concept of field cancerization,
based on the frequent tumor multiplicity and associated changes of both epithelial and
mesenchymal tissues beyond the neoplastic area (Slaughter et al., 1953). Genetic and
epigenetic changes of the epithelium have been implicated as likely primary determinants of
the field cancerization process (Chai and Brown, 2009), while alterations of the underlying
mesenchyme have received relatively little attention. The reasons for stromal alterations,
including widespread atrophic changes (Slaughter et al., 1953), are also not understood.
Notch signaling is a form of cell-cell communication with a key role in development and
tissue homeostasis (Artavanis-Tsakonas et al., 1999). The mammalian Notch gene family
codes for four closely related transmembrane receptors, whose activation depends on similar
mechanisms of ligand binding, proteolytic cleavage and nuclear translocation (Kopan and
Ilagan, 2009). The activated Notch intracellular domain associates with the DNA binding
protein CSL (CBF-1 in human and RBP-Jκ in mouse) converting it from a repressor into an
activator of transcription (Kopan and Ilagan, 2009). While Notch-independent functions of
CSL have also been reported, loss of function experiments have indicated that, in most
mammalian systems, CSL functions mainly as a Notch effector (Kopan and Ilagan, 2009).
The biological function of Notch/CSL is highly context dependent. In the skin, this pathway
plays a well-established function in keratinocyte differentiation and tumor suppression,
through both intracellular and paracrine growth control mechanisms (Demehri et al., 2009;
Dotto, 2008; Restivo et al., 2011; Watt et al., 2008; Williams et al., 2011). By contrast, the
role of this pathway in the mesenchymal compartment of the skin has been explored to a
very limited extent. We show here that mesenchymal loss of the CSL/RBP-Jκ gene is
sufficient to induce in the skin several features associated with field cancerization, which are
amenable to increased AP1 levels and activity. These findings are of likely clinical
significance, as suppression of Notch/CSL signaling and associated gene expression events
occur in stromal fields adjacent to cutaneous premalignant actinic keratosis lesions, and can
be induced by UVA exposure, a major cause of skin chronic and cancer-predisposing
alterations.
Results
1) Spontaneous multifocal keratinocyte tumors in mice with mesenchymal CSL/RBP-Jk
deletion
We recently reported that maintenance of the hair follicle keratinocyte cell fate is
compromised in mice with mesenchymal deletion of the CSL/RBP-Jk gene (ColICre x RBP-
Jκ loxP/loxP), due to intrinsically defective dermal papilla cells (Hu et al., 2010). These same
mice, by 2-4 months after birth, spontaneously developed multiple keratinocyte tumors
histologically resembling squamous cell carcinoma (SCC) precursor lesions of the actinic
keratosis / Bowen’s disease type (Fig. 1A-D; Fig. S1A). These lesions were characterized by
irregular architecture/expansion of the epidermis, acanthosis, dyskeratosis and several
features of incipient malignant disease, including discontinued laminin basement membrane
deposition, co-expression of epithelial and mesenchymal markers, and microinvasion (Fig.
1A,B, and data not shown). Tumor stroma alterations included expression of cancer-
associated fibroblast (CAF) markers (S100A4, alpha Smooth Muscle Actin) and cancer
associated matrix proteins (Tenascin C, Periostin) with a gradient of expression (Fig. S1A,
D). Increased matrix metalloprotease levels and inflammatory infiltrates were also observed
(data not shown). In 6 months old mice, tumors exhibited features of malignant SCCs, with
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aberrant keratinization, pronounced dysplasia and inflammatory infiltration, and invasion of
epithelial islands or spindle-shaped cells into dermis and connective tissue (Fig. 1E, F; Fig.
S1B,C). Tumors could be successfully transplanted (data not shown).
DNA analysis of dissociated tumor cells separated from surrounding stroma showed no
deletion of the RBP-Jκ gene nor mutations in the p53 and the Ha-, Ki- and N-ras genes
(Fig.S1D,E and data not shown). Comparative genomic hybridization (CGH) revealed small
chromosomal aberrations in all examined tumors (Fig. 1G and Table S1A). Chromosomal
alterations in tumors from the same mice were only partially overlapping, pointing to
multifocal origin or separate clonal evolution, while specific chromosomal regions were
similarly affected in tumors from different mice (Fig 1G, Table S1A). These regions and/or
their human equivalents have been implicated in cancer development, most frequently
epithelial, like murine 7qC (human 15q11.2) and 8qA1.3 (Table S2). qPCR confirmed
alterations of these regions in the CGH analyzed tumors and/or tumors from additional mice
(Fig. 1H, Table S1B).
For insights into gene expression, we used laser capture microdissection (LCM) of
spontaneously occurring tumors in parallel with normal epidermis from the same mice.
Expression of ATF3, an AP1-related transcription factor with a positive role in keratinocyte
tumorigenesis (Wu et al., 2010), was increased in all LCM-dissected tumors (Fig. 1I), while
growth inhibitory genes like TGF-ß family members, p15Ink4b, p16Ink4a, p21WAF1/Cip1 and
Notch1 were down-modulated (Fig. 1J). Among positive growth regulatory genes, c-Myc,
cyclin D1, CDK4, CDK6, E2F1, p63- and Wnt-related genes were not up-regulated or even
decreased and, consistent with the complex role of NF-κB signaling in keratinocytes (Hinata
et al., 2003), members of this family were differentially modulated (Fig. S1F).
2) Early skin changes in mice with mesenchymal CSL/RBP-Jκ deletion
Stromal atrophy was linked with field cancerization in the initial clinical report (Slaughter et
al., 1953). Decreased dermal thickness and reduced elastic fibers and collagen content were
found in skin of mutant mice at birth, when hair follicle are still normal (Hu et al., 2010)
(Fig. 2A-C; Fig. S2A,B), and at 3 weeks of age, in regions of conserved hair follicle
structure and density and when both mutant and control mice had entered the telogen phase
of the hair cycle (Fig. 2A, Fig. S2A,C). Collagen I and Elastin mRNA expression was
unaffected (not shown), while Collagen I protein levels were reduced in skin of mutant
mice, with increased ratio of soluble versus insoluble forms (Fig. 2D). Consistent with a
proteolytic mechanism, mutant mice had elevated dermal MMP activity already at birth
(Fig. 2E). Expression of a CAF marker, Periostin, but not Tenascin C, was also increased in
these mice at this time (Fig. S2D and data not shown). Dermal fibroblasts density and
proliferative index were similar to controls, with lower apoptosis (Fig. S2E-G).
BrdU labeling indicated that proliferation of interfollicular keratinocytes was already
increased in P0 mutant mice (Fig. 2F). This was accompanied by increase of phosphorylated
activated form of Fibroblast Growth Factor Receptor 1, which occurred already in mutant
E16.5-E18.5 embryos (Fig. 2G,H) together with augmented expression of mitogenic FGFs
by underlying dermal fibroblasts (shown below). Loricrin, a differentiation marker
important for skin barrier function, was down-modulated in mutant E16.5-E18.5 embryos
and P0 mice (Fig. 2I), with increased transepidermal water loss (TEWL) at birth that
normalized in later days (Fig. S2H).
LCM, followed by qRT-PCR, showed loss of RBP-Jκ expression in mutant embryos dermis,
with no decrease in epidermis (Fig. S2I). Parallel qRT-PCR analysis confirmed decreased
loricrin expression in epidermis of mutant embryos and P0 mice, with similar down-
modulation of another late differentiation marker, SPRR1a (Fig. 2J). RT-PCR analysis
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showed also deregulation of many growth factors and cytokines in epidermis of mutant
embryos and mice, which may contribute to their later phenotype (Fig. 2J).
3) Role of inflammation in spontaneous skin tumor development
Inflammation is an important determinant of chronic tissue alterations leading to cancer.
Inflammatory cells, identified by anti-CD45 staining, became detectable in dermis of mutant
mice a few days after birth, followed by localized inflammatory infiltrates and concomitant
expression of Tenascin C and, in overlying epidermis, Keratin 6, a marker of epidermal
hyperplasia (Fig. 2K). Foci of inflammatory infiltrates and Tenascin C and Keratin 6
expression expanded significantly in subsequent days (Fig. 2K), together with recruitment of
macrophages (Fig. 2K,L). LCM of stromal tissue followed by qPCR showed similar levels
of RBP-Jκ gene deletion in unaffected versus focally altered areas (Fig. S2L), pointing to
the importance of more indirect events.
For wider view of skin than permitted by immunohistochemical analysis, we adopted a
technique, Fluorescence Diagnosis (FD), used in the clinic for imaging of hyperplastic,
premalignant and malignant keratinocytic lesions (Krammer and Plaetzer, 2008). FD is
based on preferential uptake of 5-aminolevulinic acid (5-ALA) by hyperproliferative cells
and conversion into porphyrins detectable by fluorescence excitation. Relative to littermate
controls, back skin of mutant mice already exhibited stronger and widespread FD signal at
birth (Fig. 3A), consistent with increased keratinocyte proliferation detected by BrdU
labeling (Fig. 2F). Discrete regions of higher FD positivity, likely corresponding to foci of
inflammatory infiltration and epidermal hyperplasia, were also found, which increased in
number over time, eventually coalescing and marking areas of multifocal tumor
development (Fig. 3A,B).
To assess the role of inflammation, (ColI-Cre x RBP-JκloxP/loxP) mice were treated with
Celebrex, a broad anti-inflammatory agent and COX-2 inhibitor. When treatment was
started at birth, strength and expansion of FD signal, as well as eventual tumor formation,
were significantly counteracted, even if not totally suppressed (Fig. 3C,D; Fig. S3A). By
contrast, no such effects were observed when the treatment was initiated after tumor
development (Fig. S3B), consistent with the chromosomal alterations that have occurred by
this time and findings that suppression of inflammation can prevent but not reverse
tumorigenesis (Colotta et al., 2009).
4) Tumor enhancing mechanisms of CSL-deficient dermal fibroblasts
Full-thickness grafting of skin of mice with the mesenchymal CSL/RBP-Jκ deletion onto
immuno-compromised animals resulted in similar epidermal hyperproliferation and
underlying dermal alterations, such as increased Tenascin C and MMP3 expression and
decreased elastic fibers and collagen content. With time, the grafts gave rise to tumors
similar to those of the original mice (data not shown).
To assess whether dermal fibroblasts with CSL/RBP-Jκ deletion were intrinsically endowed
with tumor-promoting capability, they were admixed with weakly tumorigenic mouse
(Pam212) (Roop et al., 1983) or human (SCC13) (Rheinwald and Beckett, 1981)
keratinocyte lines, followed by injection into immune compromised mice at the dermal-
epidermal junction, i.e. a location approximating that of malignant skin tumor formation
(Wu et al., 2010). Tumors formed in the presence of RBP-Jκ −/− fibroblasts were
significantly larger than controls (Fig. 4A), with increased proliferation (Fig. 4B) and
cellularity (Fig. 4C) and decreased differentiation (Fig. 4D). There was disruption of
Laminin basement membrane deposition (Fig. 4E), loss of E-Cadherin (Fig. 4F) and
increased MMP3 production in surrounding matrix (Fig. 4G).
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An important question was whether fibroblasts with RBP-Jκ deficiency can also impact on
normal keratinocytes prior to transformation. Intra-dermal injection of human primary
keratinocytes (HKCs) in combination with control fibroblasts gave rise to large epidermal
islands with tightly adherent layers of keratinocytes and pronounced granular layer
differentiation (Fig. 4H). By contrast, HKCs admixed with RBP-Jκ −/− fibroblasts gave rise
to islands with loosely connected keratinocytes and signs of cellular atypia (Fig. 4H), higher
BrdU labeling index (Fig. 4I) and decreased expression of “early” differentiation markers
like Keratin 1 (Fig. 4J). Basement membrane laminin deposition was uneven (Fig. 4K), with
increased Tenascin C and Periostin expression in surrounding stroma (Fig. 4L,M).
To probe into underlying mechanisms, freshly isolated fibroblasts from P0 mice with and
without RBP-Jκ deletion were analyzed for expression of growth factors/cytokines, matrix
components and remodeling enzymes. Growth factor genes such as FGF7 and 10, Igf2, and
CSF-1, which promote keratinocyte proliferation and/or inflammation (Wagner et al., 2010;
Werner et al., 2007), were up-regulated in several independent preparations of RBP-Jκ −/−
fibroblasts versus controls (Fig. S4A). Matrix metallo-proteases (MMP2, 3, 9 and 13) and
Tenascin C and Periostin were similarly up-regulated (Fig. S4A). Expression of alpha
Smooth Muscle Actin (ACTA2) and PDFG Receptor α isoform (PDGFRα) was also
enhanced, while that of other CAF markers, like PDGFRβ, FAP, S100A4 and Desmin, was
not affected or even decreased (Fig. S4A and data not shown). Similar modulation of gene
expression was observed with cultured dermal fibroblasts from RBPJk −/− mice and
fibroblasts with the “floxed” RBP-Jκ gene after “acute” deletion by a Cre-expressing
adenovirus (Fig. S4B,C). Dermal fibroblasts express both Notch 1 and 2 receptors. siRNA-
mediated knockdown of Notch1 and, to a greater extent, Notch2 resulted in suppression of
the canonical Hes1 target gene and concomitant up-regulation of genes induced by the RBP-
Jk deletion (Fig. S4D).
For further insights, we resorted to cDNA microarray analysis of dermal fibroblasts from P0
mice plus/minus RBP-Jκ deletion in parallel with cultured dermal fibroblasts plus/minus
deletion of the "floxed" RBP-Jκ gene by Ad-Cre. 381 genes were found similarly modulated
as a consequence of RBP-Jκ deletion. Among significant biological processes to which up-
regulated genes could be assigned were "DNA damage and Stress Response", "tissue
remodeling and wound repair", "vasodilation" and "inflammatory response" (Fig. S4E). c-
Jun/AP1 was a prominent transcription factor in the network that could be built from the
validated set of genes deregulated by RBP-Jκ deletion (Fig. S4F). Involvement of various
AP1 family members was assessed further below. Other relevant genes included mediators
of cell-matrix and cell–cell interactions (CD44, Syndecan-1 (SDC1), Hyaluronan synthase 2
(HAS2) and Hyaluronan-mediated motility receptor (HMMR ), kinases (MAP2K3, MAPK6,
MAPK14, Prkar2a) and trascription factors (Ets1 and NFATc3) involved in stress and/or
growth responses, and determinants of inflammation (COX2, CSF-1, IL17RA). Increased
expression of these genes, as well as of FGF7 and FGF10, was confirmed by LCM and qRT-
PCR of dermis from P0 mutant versus wild type mice, and E16.5 and E18.5 embryos (Fig.
S4G).
Mesenchymal loss of the PTEN gene was reported to enhance mammary tumor development
driven by transgenic oncogene expression, with induction of a CAF phenotype that overlaps
only partially with the one caused by RBP-Jκ deletion (Trimboli et al., 2009). Given
previous work linking Notch signaling to control of PTEN expression (Demarest et al.,
2008), we examined expression of this gene, but found similar levels in mutant fibroblasts
and controls (Fig. S4A,B).
A common feature of many genes up-regulated in RBP-Jκ −/− fibroblasts is that they are
under positive AP-1 control. Notch/RBP-Jκ signaling can function as negative regulator of
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AP-1 activity, also through modulation of various AP-1 family members (Chu et al., 2002;
Talora et al., 2002). Consistent with these previous findings, expression of several AP1
family members was up-regulated in dermal fibroblasts from mutant mice and embryos (Fig.
5A-C; Fig. S4G; Fig. S5A,B), and fibroblasts with Notch1 and Notch2 knock-down (Fig.
S4D).
To assess which AP1 family members are more functionally important, we evaluated the
consequences of their knocked down expression in RBP-Jκ −/−fibroblasts. Down-
modulation of c-Jun or c-Fos returned expression of all tested growth factors, cytokines,
matrix components and MMPs to levels close to control cells (Fig. 5D, Fig. S5C,D).
Knockdown of other AP1 family members could counteract up-regulation of MMP3
expression, while had more limited and selective effects on other genes (Fig. S5E).
To assess the in vivo significance of these findings, RBP-Jκ −/− fibroblasts transfected with
anti-c-Jun siRNAs versus scrambled controls were admixed with SCC13 cells, followed by
intradermal injection into mice. Tumors formed in the presence of RBP-Jκ −/− fibroblasts
with c-Jun knockdown had lower weight, with pronounced apoptosis/necrosis of cells in
central areas and reduced proliferation, and enhanced differentiation of cells at the periphery
(Fig. 5E-H, Fig. S5F-I). Differences in tumor formation were accompanied by decreased
expression of CAF markers in surrounding stroma together with decreased MMP expression
and activity (Fig. 5I, J; and data not shown).
5) Relevance to human skin
An important question was whether down-modulation of CSL signaling can lead to a CAF-
like phenotype in human cells. shRNA-mediated knock-down of CSL (RBP-Jκ) in 2
independent strains of human primary dermal fibroblasts resulted in reduced expression of
the “canonical” Notch targets Hes1 and Hes5, as well as of Notch1 and 2 receptors, and
Notch ligands Jagged 1 and 2 (Fig. 6A; Fig. S6A). Expression of c-Jun and c-Fos, and many
other genes up-regulated in mouse RBP-Jk −/− cells, was similarly affected in human
dermal fibroblasts with CSL knockdown (Fig. 6A; Fig. S6A,B). As in xenografts with
mouse fibroblasts, SCC13 cells admixed with human dermal fibroblasts with CSL
knockdown formed tumors of greater size and cellularity and more disordered differentiation
than the controls, with up-regulation of Tenascin C and Periostin expression in surrounding
stroma (Fig. 6B-D; Fig. S6C and data not shown).
To assess the relevance of the above findings to the clinical situation, we used LCM of
surgically excised skin samples from patients with lesions preceding SCC formation.
Analysis of stroma underlying areas of premalignant lesions (actinic keratosis, AK) along
with skin fields farther away, revealed consistent inverse relation between expression of
Notch receptors, Hes1 and Hes5 versus c-Jun, c-Fos and other genes under negative Notch/
CSL control, like, CAF markers, CD44 and COX-2, in the lesion-underlying stroma (Fig.
7A). The LCM and qRT-PCR results were further validated by immunofluorescence
analysis of excised skin regions, showing decreased Notch2 signal intensity with
concomitant up-regulation of c-Jun in the Vimentin-positive cells of the AK-underlying
stroma versus flanking skin (Fig. 7B; Fig. S7A-C).
UV light exposure is a major etio-pathological agent of premalignant and malignant skin
cancer formation (Rittie and Fisher, 2002). While UVB has limited penetration power and
its effects are mostly limited to epidermal cells, UVA can also directly affect cells of
underlying dermis. UVA - but not UVB - irradiation of human skin explants followed by
LCM of upper dermal compartment and qRT-PCR showed significant down-modulation of
Notch1, Notch2 and Hes1 genes even at lowest doses, while c-Jun expression was up-
regulated (Fig. 7C and data not shown). In time course experiments, modulation of these
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genes occurred as early as 1 hour after UVA exposure and persisted up to 5 days (Fig. 7C;
Fig. S7D-F).
For further insights, we focused on the Notch2 gene. As with skin explants, down-
modulation of this gene, and up-regulation of c-Jun, occurred in cultured human dermal
fibroblasts, within 20′ of UVA exposure, persisting up to 5 days (Fig. S7G). Nascent
Notch2 transcripts, detected by qRT-PCR of the first exon-intron junction, were also down-
regulated at late times of UVA exposure as mature transcripts (Fig. S7G). Persistent down-
modulation would be consistent with a permanent modification of the Notch2 transcription
locus. In fact, PCR analysis of methylation-enriched DNA samples from dermal
compartment of skin explants and cultured dermal fibroblasts, indicated that the GC-rich
region of the Notch2 promoter was increasingly methylated as a function of time after UVA
exposure, with no increased methylation of a distal GC-rich region of the same gene (Fig.
7D and Fig. S7H). Importantly, similar differences in methylation of the Notch2 promoter
were found in the clinical situation, in stroma underlying AK lesions versus skin fields
further away (Fig. 7E).
Discussion
Field cancerization is a clinical condition of major significance for cancer recurrence and
lethality, which is still poorly understood (Chai and Brown, 2009). It can develop at various
body sites, among which the skin is the most common. Development of mouse genetic
models to probe into underlying molecular defects would be highly desirable. The skin
phenotype of mice with mesenchymal RBP-Jκ deletion presents several features that are
reminiscent of those found in field cancerization. The clinical process is associated with a
“diagnostic triad” of multifocal tumors, expanding alterations of the surrounding epithelium
and atrophic changes of the underlying stroma (Slaughter et al., 1953). Among these, the
stromal atrophy of RBP-Jκ mutant mice is a feature that has not yet been observed, to our
knowledge, in any other mouse cancer model. The similarity to the clinical situation of
expanding multifocal lesions detected by the fluorescence diagnosis technique is also
remarkable.
The earliest biochemical alterations resulting from RBP-Jκ deletion in dermal fibroblasts
include increased expression of genes with mitogenic and/or pro-inflammatory function in
both fibroblasts and overlying keratinocytes. These in turn can elicit further changes, most
notably an inflammatory reaction, both directly and through transiently compromised skin
barrier function. Recruitment of inflammatory cells is followed by localized infiltrates,
possibly by an initially weak (and stochastic) signal, which is then amplified by an
immunological cascade. Locally increased inflammation is likely to be a determining factor
of other focal changes in dermis and overlying epidermal tissue. Inflammation is also known
to increase chromosomal instability (Colotta et al., 2009) and could thus contribute to later
multifocal tumors, which we found associated with specific chromosomal alterations.
Treatment of RBPJκ mutant mice with a COX-2 inhibitor as anti-inflammatory agent
delayed formation of focal lesions and tumors, raising the exciting prospect that, even in
patients with field cancerization, inhibition of inflammation, even if not sufficient to reverse
tumorigenesis, could be used to prevent or retard secondary tumor development. In line with
this possibility is our other finding that COX-2 expression is up-regulated in both mouse and
human fibroblasts by loss of CSL/RBP-Jκ function and in the clinical situation, in stroma
underlying actinic keratosis lesions versus skin fields further away.
Similar changes in gene expression were elicited by loss or down-modulation of the CSL
gene and knock-down of Notch1 and Notch2. These included up-regulated expression of
several AP1 family members. Consistent with their shared key role (Eferl and Wagner,
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2003), down-modulation of c-Jun or c-Fos had the most significant effects in RBP-Jκ
deficient fibroblasts, reverting expression of all tested deregulated genes. Even in vivo, the
tumor enhancing effects of RBP-Jκ −/− fibroblasts were counteracted by the c-Jun
knockdown. Importantly, an inverse relationship between Notch/CSL activity and c-Jun/c-
Fos expression was also found in excised skin samples from enrolled patients with
cutaneous field cancerization, in stromal fields underlying actinic keratosis versus distant
normal epidermis.
Basal level of Notch activity in dermal cells (as also observed by use of a reporter mouse,
our unpublished observations) can be explained by concomitant expression of Notch
receptors and ligands by the same or neighboring cells. In the present context, we were
concerned with exogenous signals that cause down-regulation of this pathway. Cutaneous
field cancerization usually develops in sun-exposed areas in elderly people or
immunosuppressed patients, and is defined by the appearance of multiple actinic keratosis
lesions on damaged skin. UVA light exposure can directly affect the dermis and its
importance in UV-induced carcinogenesis is increasingly recognized (Ridley et al., 2009).
We have found that UVA, but not UVB, exposure has a rapid negative impact on expression
of Notch receptors and downstream targets in the dermis of human skin explants and dermal
fibroblasts, in parallel with c-Jun and c-Fos up-regulation. This is in contrast to the
consequences of UVB exposure of human epidermis and keratinocytes, which elicits a p53-
dependent upregulation of Notch1 expression as a pro-survival and pro-differentiation
reaction (Mandinova et al., 2008; Yugawa et al., 2007).
A very early consequence of UVA exposure is production of radical oxygen species (ROS)
with consequent ligand-independent activation of EGFR/ERK/AP1 signaling (Rittie and
Fisher, 2002). While increased ERK/AP1 activity can negatively regulate Notch1 expression
and activity (Kolev et al., 2008), down-modulation of Notch signaling enhances AP1
activity. Thus, a negative feedback loop between the two pathways can be involved in the
initial impact of UVA exposure on gene expression. A concomitant attractive mechanism is
provided by epigenetic modifications, which we have found to occur shortly after UVA
exposure at level of the Notch2 promoter. This is consistent with recent findings of a
recruitment of DNA methyltransferase I (DNMT1) and methylation of selective GC rich
promoters in rapid response to increased ROS levels (O’Hagan et al., 2011). DNA
methylation of the Notch2 promoter could account for sustained down-modulation of the
gene and be of considerable clinical significance, as we found that the Notch2 promoter is
also differentially methylated in vivo, in actinic keratosis underlying stroma versus skin
fields further away. DNA methyl transferase inhibitors are already approved for clinical
trials of cancer treatment (Baylin and Jones, 2011) and an exciting possibility is that these
compounds can also be employed for preventing and/or reversing stromal alterations
associated with field cancerization.
Methods
Mice and human samples
Development of mice with mesenchymal RBP-Jκ deletion was previously reported (Hu et
al., 2010) . All mouse work was performed according to the Swiss guidelines and
regulations for the care and use of laboratory animals. Human skin samples for primary cell
preparation were obtained from abdominoplasty procedures at the Department of Plastic,
Reconstructive and Aesthetic Surgery, Lausanne University Hospital (Switzerland) with
patients’ and institutional approvals. Samples of actinic keratosis and SCC were obtained
from clinical biopsies at the Departments of Dermatology, University of Tübingen
(Germany), and Zurich University Hospital (Switzerland). Parts not needed for histological
diagnosis were further processed with institutional review board approval.
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Cell and tissue manipulations
Conditions for culturing of cells, organ explants, viral infection and siRNA transfection
were previously reported (Hu et al., 2010; Kolev et al., 2008; Wu et al., 2010). Full
thickness grafting of mouse skin (Hu et al., 2010) and intradermal tumorigenicity assays
(Wu et al., 2010) were also as described. Detailed conditions for cell culture and in vivo
testing are provided in the web supplementary information. UV exposure was performed in
a Bio-Link crosslinker UV irradiation system (Vilber Lourmat) equipped with exchangeable
UVA (375nm) and UVB (312nm) lamps. The exposure dosage was measured with a
portable photometer IL1400A (International Light Technologies).
For more details and skin organ culture, collagen determination, LCM, and anti-
inflammatory treatment please see Extended Experimental Procedures. The list of siRNAs
and shRNAs used for this study is provided in Table S3.
qRT-PCR and cDNA microarray analysis, LCM and methylated DNA detection
Conditions for qRT-PCR, immunoblotting and immunofluorescence and cDNA microarray
analysis were as previously described (Hu et al., 2010; Nguyen et al., 2006). The list of
gene-specific primers is provided in Table S3. PCR arrays were from SAbiosciences
(PAMM-041). LCM was performed using an Arcturus XT microdissection system (Applied
Biosystems), as before (Hu et al., 2010). Methylated DNA was isolated using
MethylCollector (Active Motif) according to the manufacturer’s protocol. Recovered DNA
was quantified with a Nanodrop 1000 spectrophotometer (Nanodrop) prior to qPCR
analysis.
Immunodetection
Antibodies are listed in Table S3. Immunofluorescence images were acquired with a Zeiss
LSM510 meta laser-scanning microscope. For quantitation of Notch 2 immunofluorescence
signal, digitally acquired images for each color channel were separately imported into Image
J software and converted into binary images. The numbers of pixels (representing the
intensity of the fluorescence signal) were measured using “Measurement” function. For
single cell Notch2 signaling measurement, Vimentin positive single cells were selected
using “Lasso Tool” in Photoshop Element 8.0 software (Adobe) and the Notch2 signal were
read out by histogram and calculated in Microsoft Excel 2004 software (Microsoft).
Fluorescence diagnosis
Newborn or adult mice (with back skin shaved 24 hours before treatment) were topically
applied 5-ALA mix (containing 10% ALA w/w (Sigma) and 20% DMSO, diluted in
distilled water) at a dosage of 10mg/cm2. 3 hours later, mice were analyzed under a
Xenogen IVIS-200 optical in vivo imaging system (Caliper Life Sciences) with excitation
wavelength at 430nm and emission wavelength at 640nm, using a DSRed filter at 1.5 cm
depth and 10 second exposure time (f2). The binning setting was 2 pixels per bin and field
of View (FOV) was 24. Intensity of the emitted signal was calculated using Living Image
3.2 software (Caliper Life Sciences). For newborn animals (P0-P6), the minimum/maximum
of reading was set at 3.5e6/8e7 photons/s; for adult mice the minimum/maximum was set at
3e7/3e8.
Array Comparative Genomic Hybridization (CGH)
Excised skin tumors were minced into small pieces and digested in 1% Collagenase I
(Sigma; 37oC for 1 hour) for removal of stromal tissue. The resulting suspension was
filtered through a 40mm mesh and epithelial fragments were used for DNA extraction, using
a Wizard® Genomic DNA Purification Kit (Promega). Tumor DNA samples were labelled
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with Cy3 and hybridized to Nimblegen mouse CGH arrays together with Cy5-labelled
normal brain DNA extracted from the same mice. Arrays contained 2.1 million probes
across the whole genome based on the MM9 genome build. CGH was according to
Nimblegen protocols. Scanning with an Agilent G2565BA Microarray Scanner was
followed by image and data processing using Nimblescan software v.2.5. Data can be
accessed through the Gene Expression Omnibus number: pending.
Statistical analysis
PRISM software (Graph Pad Software Inc.) was used to assess statistical significance of the
results, employing one-way ANOVA followed by Bonferroni’s test, except for RNAi
experiments for Jun B, Jun D, FosB, FosL1, FoL2, and shRNA experiments, where
Dunnett’s test was applied.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
1. Mesenchymal loss of CSL/Notch results in field cancerization of the skin
2. Pro-tumorigenic consequences of CSL loss are linked to c-Jun/c-Fos
upregulation
3. Anti-inflammatory treatment counteracts the field cancerization phenotype
4. UVA exposure down-modulates Notch signaling and expression through DNA
methylation
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Figure 1. Mesenchymal CSL/RBP-Jκ deletion results in spontaneous skin tumor formation
(A) Overview of multiple spontaneous skin tumors in a mouse with mesenchymal RBP-Jκ
deletion (ColI-Cre x RBP-JκloxP/loxP) at 4 months.
(B) Low and high magnification histological images of spontaneous tumors and surrounding
skin in 4 months old mice. Tumors at this stage exhibited features of in situ carcinomas of
keratoacanthoma and/or Bowen’s disease type, with disrupted epidermal architecture,
parakeratotic nuclei and foci of aberrant keratinization. Immunohistochemical analysis of
tumor stromal component is shown in Fig. S1A, D.
(C) Number of tumor-bearing mice with mesenchymal RBP-Jk deletion (−/−) versus
littermate controls (+/+) until 18 weeks after birth or earlier, if mice had to be sacrificed due
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to tumor burden. Fraction of males and females was similar, with no differences in tumor
formation.
(D) Number of independent (physically separated) tumors in mutant mice. Shown are
average tumor numbers per mouse per time point, as well as variation among individual
mice. Values may be underestimated, due to coalescence of individual lesions.
(E) Histology of skin tumors in mice at 6 months of age. Higher magnification analysis
showed loss of epidermal architecture, pronounced cellular atypia and inflammatory
infiltration (Fig. S1B). Lesions with similar characteristics were found in 7 of 7 mice that
survived until this age. Tumors were classified as well to moderately differentiated SCCs
(Grade I-II).
(F) Immunohistochemical analysis with anti-Pankeratin antibodies showing invading
epithelial islands and tumor front in a 6 months old mouse. Quantification of results is
provided in Fig. S1C.
(G) Summary of CGH DNA analysis of skin tumors versus unrelated normal tissue (brain)
from the same mice. For each tumors are listed specific chromosomal regions that were
duplicated (+), deleted (−) or, for pairs of tumors derived from the same mouse, unaffected
(N). Raw CGH data and statistical significance are provided in Table S1A. Statistical
permutation tests showed that the repeated identification of 4 overlapping rearrangements in
5 mice (as found, for instance, for 7qC and 8qA) is highly significant (P = 0.0005).
(H) Upper : Map of mouse chromosomal 7qC region and overlapping segments of
duplication (green bars) in the indicated multiple tumors. Maps of other chromosomal
regions with overlapping alterations in multiple tumors are provided in Table S1A. Lower:
qPCR analysis of tumor and normal DNA samples utilized for CGH was performed with
primers for three sites within the 7qC region (indicated by arrows in the previous panel).
Results are in arbitrary units after internal normalization for an unrelated chromosomal
region (15qB3.1). Similar results were obtained after normalization for three other
chromosomal regions (5qC1 and 13qB1, data not shown). Further qPCR analysis showed
duplications of the 7qC and 8qA regions in 4 and 5 additional tumors, respectively, out of 6
that were analyzed, from 3 more mice (Table S1B).
(I) and (J), qRT-PCR analysis of LCM samples from tumors versus flanking normal
epidermis (identified by double immunofluorescence with anti-K14 and -Tenascin C
antibodies, as shown in Fig. S1D) from two mice, two tumors per mouse. Expression of
indicated genes is in arbitrary units utilizing ß-Actin for normalization. Analysis of other
genes is in Fig. S1F. *: p<0.01 by one way ANOVA followed by Bonferroni’s test.
Scale bars: 200μm for B and D; 40μm for C and E.
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Figure. 2. Early skin defects in mice with mesenchymal CSL/RBP-Jκ deletion
(A) Dermal thickness (distance between dermal-epidermal junction and panniculum
carnosum; double end arrows) was quantified in five RBP-Jκ mutant mice and five controls
(black and white bars) at 4 days and 3 weeks of age (* p<0.01). Histological images are in
Fig. S2A.
(B) Verhoeff-Masson-trichrome staining and quantification of elastic fibers (x105/mm2) in
back skin dermis of two P4 mice per genotype, counting 3 independent fields for each
section (* p<0.01).
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(C) Masson-trichrome staining of total collagen in P4 mouse skin (blue) with Nuclear Fast
Red for counterstaining. Images are representative of four mice per genotype. Collagen I and
III immunostaining is in Fig. S2B.
(D) Biochemical quantification of total collagen and ratio of soluble versus insoluble
fractions in 3 weeks old mice. 5 mice per genotype were analyzed. (* p<0.01).
(E) In situ zymography of P4 mouse skin with MMP3 and MMP13 preferential substrates.
Little signal was observed in presence of MMP inhibitor GM6001 (not shown). MMP
activity in epidermis and hair follicles is likely due to diffusion, consistent with MMP3 and
MMP13 mRNA levels being increased selectively in fibroblast compartment of RBP-Jκ
mutant mice (Fig. S4A and data not shown). Increased MMP3 and MMP13 protein
expression in skin of mutant mice was also observed by immunohistochemistry (not shown).
(F) P0 mice were injected with BrdU, followed by BrdU labeling determination in
interfollicular epidermis. Four mice per genotype were analyzed (* p<0.01).
(G) Immunofluorescence of back skin sections of E16.5 and E18.5 embryos and P0 mice
with antibodies recognizing the activated phospho-Tyr 653/654 form of FGFR1 and, to a
less extent, other FGF receptors. Images are representative of 3-4 independent fields, 2 mice
per genotype.
(H) Immunofluorescence signal intensity in epidermal compartment of above skin samples
by computer-assisted quantification (* < 0.01).
(I) Immunofluorescence of back skin sections of E16.5 and E18.5 embryos and P0 mice
with antibodies against Loricrin. Images are representative of 3-4 independent fields, 2 mice
per genotype.
(J) Epidermal compartment of E16.5 and E18.5 embryos and P0 mice was analyzed by LCM
followed and RT-PCR arrays for cytokines and growth factors. Results are shown as heat
map fold changes of expression of indicated genes in mutant versus control samples.
(K) Immunofluorescence analysis of P6 and P10 mouse back skin, illustrating foci of
leukocyte infiltration (CD45 positive) and Keratin 6 (K6) and Tenascin C expression.
Parallel immunofluorescence with anti-K6 and F4/80 antibodies illustrated hyperplastic
epithelium and infiltrating macrophages, respectively.
(L) Quantification of focal lesion size (CD45 positive areas demarked by arrows in the
previous panel) showing a time-dependent increase. Large skin sections, 5 lesions per
mouse, two mice per time point, were analyzed (*<0.01).
Scale bars: 20μm for A, C, G and I; 200 μm for E and K.
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Figure 3. Expanding multifocal skin lesions and counteracting effects of anti-inflammatory
treatment as detected by Fluorescence Diagnosis (FD)
(A) Mice at indicated times after birth were topically treated with 5-ALA, followed by
fluorescent light excitation and digital image acquisition, using same exposure conditions
for age-matched mutant (−/−) and control (+/+) animals. FD signal intensity (x1e8 photons/
sec/cm2/sr) was calculated as in (Troy et al., 2004) (* p<0.01).
(B) Intense FD positivity in mouse mutant back skin at > 4 weeks of age corresponds to
multifocal areas of tumor development (areas of macroscopic pictures marked by dotted
lines).
(C) Mice with mesenchymal RBP-Jκ deletion were treated, starting at birth, with the COX2
inhibitor Celebrex or vehicle alone (intraperitoneal injections, 20μg per g body weight, in
DMSO, twice weekly, 5 mice per group), followed by FD analysis at indicated times.
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(D) Quantification of FD signal intensity and body surface with high FD signal (above a
threshold of 2e7 photons/sec/cm2/sr for mice up to 6 days old and 1.5e8 photons/sec/cm2/sr
for older mice) for each mouse (*<0.01). For macroscopic and histological images of mice
at the end of the experiment, see Fig. S3A.
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Figure 4. RBP-Jκ deficient dermal fibroblasts enhance growth/tumorigenic behavior of SCC-
derived and normal primary keratinocytes
(A) Weakly tumorigenic mouse (Pam212) or human (SCC13) keratinocytes were admixed
with cultured (second passage) dermal fibroblasts from mice plus/minus RBP-Jκ deletion
prior to injection at the dermal-epidermal junction of NMRI athymic mice. Mice were
sacrificed for tumour weight determination either 1 or 8 weeks later. Weight difference
between tumor pairs in each mouse and between the two groups of tumors was highly
significant (* p<0.01).
(B) Mice as in previous panel were BrdU labeled for 2 hours prior to sacrifice, followed by
determination of BrdU labeling of keratinocyte tumor cells (identified by Keratin 14
staining) in presence of control versus RBP-Jκ −/− fibroblasts (* p<0.01).
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(C) Histological analysis of tumors formed by SCC13 cells admixed with dermal fibroblasts
plus/minus RBP-Jκ deletion 8 weeks after injection. Shown are low and corresponding high
magnification images (left and right panels, boxed areas).
(D-G) Immunofluorescence analysis of the indicated proteins in tumors formed by SCC13
cells admixed with fibroblasts plus/minus RBP-Jκ deletion. Besides the epithelial-
mesenchymal border, basement membrane of underlying blood vessels (BV) is also positive
for Laminin staining (E). Dotted lines mark the epithelial-mesenchymal junction. Nuclei
were visualized by DAPI staining.
(H) Histological images of epidermal islands formed by HKCs admixed with control versus
RBP-Jκ −/− fibroblasts 1 week after intra-dermal mouse injection. Note granular layer
differentiation features in epidermal islands formed in presence of control but not mutant
fibroblasts.
(I) Mice as in previous panel were BrdU labeled for 2 hours prior to sacrifice, followed by
determination of BrdU labeling of keratinocytes (identified by Keratin 14 staining) in the
presence of control versus mutant fibroblasts (* p<0.01).
(J-M) Immunofluorescence analysis of epidermal islands formed by HKCs together with
control versus mutant fibroblasts with antibodies against indicated proteins. Scale bars:
40μm for C-F, L and M; 20μm for G, H, J and K.
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Figure 5. Dermal RBP-Jκ regulates tumor growth through AP-1
(A) Differential expression of AP-1 family members in dermal fibroblasts freshly isolated
from a pool of three newborn mice (P0) plus/minus RBP-Jκ deletion. qRTPCR results are in
arbitrary values after normalization for β-Actin (* p<0.01).
(B) Immunoblot analysis of c-Jun and c-Fos expression in freshly isolated dermal fibroblasts
from P0 mice. Densitometric scanning of autoradiographs with normalization for γ-Tubulin
showed, respectively, a 2 and 1.5 fold increase of c-Jun and c-Fos expression in mutant
versus control cells.
(C) Immunofluorescence analysis of c-Jun (red) expression in back skin of P0 mice. Dermal
fibroblasts were identified by co-staining with anti-Vimentin (green) antibodies. Dotted lines
mark dermal-epidermal borders. Additional immunofluorescence images with antibodies
against c-Jun and phospho-c-Jun and results quantification are provided in Fig. S5A,B.
(D) Expression of indicated genes in dermal fibroblasts with RBP-Jκ deletion plus/minus
siRNA-mediated c-Jun knockdown, in parallel with similarly cultured control fibroblasts
(black and white bars, respectively). qRT-PCR results are expressed in arbitrary units with
β-Actin for normalization (* p<0.01). Similar results with a second set of siRNA against c-
Jun, and siRNAs against c-Fos are shown in Fig. S5C,D. Functional consequences of knock-
down of other AP1 family members are shown in Fig. S5E.
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(E) Immunofluorescence analysis of c-Jun expression in tumors formed 1 week after
intradermal injection of SCC13 cells admixed with RBP-Jκ deficient dermal fibroblasts
transfected with siRNA against c-Jun or scrambled siRNA control. Dermal fibroblasts were
identified by co-staining with anti-Vimentin antibodies. Tumor-stromal border is indicated
by dotted lines. Similar results were obtained by immunofluorescence analysis of the other
tumors formed in presence of dermal fibroblasts plus/minus c-Jun knock-down, and are
consistent with biochemical analysis of cultured cells, showing persistent knockdown effects
for at least one week after siRNA transfection.
(F) Histological analysis of tumors formed by SCC13 cells admixed with RBP-Jκ deficient
fibroblasts plus/minus c-Jun knock-down as in the previous panel. To minimize individual
animal variations, mice were injected in parallel with the two combinations of cells. Shown
are low and corresponding high magnification images (left and right panels, boxed areas). In
the tumor formed by SCC13 cells admixed with RBP-Jκ −/− fibroblasts with c-Jun knock-
down, pronounced apoptosis and necrosis of cells in the more central areas resulted in tissue
loss - and an empty space -at the time of cutting. Similar findings were obtained with other 4
tumor pairs as shown in Fig. S5F-I, and with 5 additional tumor pairs from an independent
experiment (not shown).
(G) Mice as in (E,F) were BrdU labeled for 2 hrs prior to sacrifice. BrdU labeling of tumor
keratinocytes (identified by Keratin 14 staining) admixed with RBP-Jκ deficient fibroblasts
plus/minus c-Jun knockdown (black and white bars, respectively) was determined in parallel
with tumor weight (* p<0.01).
(H-J) Same samples were analyzed by immunostaining for Keratin 1 (H) and Tenascin C (I)
and in situ zymography with a preferential MMP13 substrate (J). Asterisks indicate the
epithelial tumor compartment.
Scale bars: 20μm for C, E, F (right two panels), H-J; 200μm for F (left two panels).
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Figure 6. Tumor-enhancing phenotype of human dermal fibroblasts with CSL knock-down
(A) Human dermal fibroblasts (HDFs) were infected with two anti-CSL shRNA lentiviral
vectors (#1 and 2; black bars) in parallel with empty vector control (white bar), followed by
6 days selection for puromycin resistance. Cells were analyzed by qRT-PCR for indicated
genes, using 36β4 for normalization(*p<0.01). Analysis of an independent strain of HDFs
plus/minus CSL knockdown is shown in Fig. S6A,B.
(B) SCC13 keratinocytes were admixed with HDFs plus/minus CSL knockdown (by shRNA
vector #1) prior to intra-dermal injection into NMRI athymic mice. Each mouse received
parallel injections of keratinocytes admixed with control versus CSL knockdown fibroblasts
(white and black bars, respectively). Mice were sacrificed for tumor weight determination 8
weeks later (* p<0.01).
(C) Histological analysis of tumors formed by SCC13 cells admixed with HDFs plus/minus
CSL knockdown. Shown are low and high magnification images. Histological analysis of
other tumors is shown in Fig. S6C.
(D) Immunofluorescence analysis of tumors from the above experiment with antibodies
against indicated proteins.
Scale bars: 100μm.
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Figure 7. Down-regulation of Notch signaling in stromal fields adjacent to keratinocyte pre-
malignant lesions and impact of UVA exposure
(A) Excised skin samples from 10 patients, containing, in each case, a field of normal
epidermis well separated from one with actinic keratosis (AK) lesions were utilized for
LCM of the AK underlying stroma versus stroma fields further away, followed by qRT-PCR
analysis of indicated genes, using 36β4 for normalization. Results are expressed as heat map
of fold changes of the indicated genes in AK-underlying stroma versus stroma further away.
Expression of a less complete set of genes could be assessed in part of the cases (from
patients #6-10), because of limited sample availability. Effectiveness of the LCM procedure
was evaluated by histological analysis of each skin sample before and after stromal removal.
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Only upper stromal regions immediately adjacent to the epithelium were captured, which,
even in the AK underlying regions, were relatively free of leukocytes (localized instead to
the deeper regions). The possibility that leukocyte contamination contributes to observed
differences in gene expression was further ruled out by qRT-PCR analysis, showing that
Notch1 and 2 expression was, if anything, higher in purified leukocyte than fibroblast
populations, with the reverse being observed for other genes like c-Jun (data not shown).
(B) Triple immunofluorescence analysis with antibodies against Notch 2 (green), c-Jun (red)
and Vimentin (light blue) of an excised skin sample with an AK lesion. Upper panel: low
magnification image illustrating the expected pronounced expression of Notch 2 in upper
epidermal layers with Notch2 down-modulation and c-Jun up-regulation in the AK lesion
(yellow arrow). Lower panels: higher magnification images for assessment of Notch 2
(green) and c-Jun (red) expression in Vimentin positive (blue) dermal fibroblasts of stromal
fields underlying normal epidermis, a transition zone and AK lesion as indicated (fields 1, 2
and 3, respectively). The Notch2 fluorescent signal masked the Vimentin signal and single
channel image analysis was used for quantification of Notch2 versus c-Jun signal intensity
in Vimentin positive cells (right panel). For this, acquisition of digital images was followed
by computer-assisted determination of fluorescence intensity on an individual cell basis.
Dots refer to individual measurement values (*p<0.01). Scale bars: 200μm, (upper panel);
20μm (lower panels). Analysis of additional AK-containing skin excisions is shown in Fig.
S7A-C.
(C) Freshly excised human skin samples placed in semi-solid culture medium and treated
with indicated doses of UVA (J/cm2) were withdrawn at indicated times thereafter (hours,
days). LCM of upper dermal region followed by qRT-PCR was used to assess expression of
indicated genes (*p<0.01). Similar results were obtained in other independent experiments
with human skin explants and with experiments with cultured human dermal fibroblasts
(Fig. S7D-G and data not shown).
(D) Human skin explants exposed to indicated UVA doses were processed at various times
thereafter for LCM of the upper dermal region, followed by isolation of CpG-methylated
DNA by a binding protein capture method. Methylation levels of the Notch2 proximal
promoter region (161 ntd position rel. to the Notch2 start site) in untreated versus UVA-
treated samples were assessed by qPCR, utilizing total input DNA for normalization. Similar
analysis of a distal GC-rich region of the Notch2 gene (172,856 ntd position rel. to the
Notch2 start site) was performed as equal loading control of partially methylated DNA that
is not subject to UVA-induced modulation. Similar analysis of UVA-exposed dermal
fibroblasts is shown in (Fig. S7H).
(E) Same skin samples of the first five patients analyzed in (A) were utilized for LCM of
AK-underlying versus distal stromal (normal skin, NS) fields, followed by isolation of CpG-
methylated DNA as in the previous panel. qPCR analysis was used to assess methylation
levels of the Notch2 promoter and distal GC-rich region (*p<0.01).
Scale bars: 200μm, (upper panel of B); 20μm (lower four panels of B).
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